Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: Dr Chiasson and colleagues1 reported that treatment with acarbose was associated
with a significant reduction in the incidence of cardiovascular disease and
hypertension among patients with impaired glucose tolerance (IGT). The authors
claimed that their study was the first to report these results. In fact, however,
my colleagues and I have previously reported that acarbose and glibenclamide
significantly reduced blood pressure levels among patients with hypertension
and type 2 diabetes.2
Rosenthal JH. Acarbose for Patients With Hypertension and Impaired Glucose Tolerance—Reply. JAMA. 2003;290(23):3066. doi:10.1001/jama.290.23.3066-a
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: